Product Description
The global surgical graft market was valued at $206 million in 2025. This is expected to increase over the forecast period at a CAGR of 0.6% to reach $215 million by 2032.
The full report on the global surgical graft market includes lower limb surgical grafts, aorta repair surgical grafts, and extra-anatomical bypass surgical grafts.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Surgical Graft Market Trends
An ongoing trend in the vascular surgical graft market is the growing adoption of endovascular techniques and minimally invasive procedures. As medical technology advances, there is a noticeable shift toward using endovascular grafts and stent grafts as alternatives to traditional open surgical procedures. These minimally invasive approaches offer benefits such as reduced patient trauma, shorter hospital stays, quicker recovery times and potentially fewer complications. This trend is driven by advancements in graft materials, improved delivery systems and the preference of both patients and physicians for less invasive treatment options. As these technologies continue to evolve and gain acceptance, they are likely to reshape the landscape of vascular surgical procedures on a global scale.
Global Surgical Graft Market Share Insights
- W.L. Gore held a prominent position in the ATK and BTK surgical graft markets, largely attributed to its PROPATEN® line, particularly within the BTK subsegment in 2025. Their PROPATEN® vascular graft has gained remarkable traction in the market due to its distinctive attributes, cost-effectiveness and robust clinical evidence. The graft is coated with heparin, an anticoagulant, which minimizes thrombus formation on its surface.
- Terumo help the second leading position throughout 2025 due to the Gelsoft™ and Gelweave™ product lines, which incorporate hydrolyzable gelatin impregnated into the coating. Gelsoft™ is made using sealed polyester, while Gelweave™ is made using a woven polyester covering. Terumo’s broad portfolio offers extensive options for both cardiac and peripheral applications.
- Maquet held the third position in the market through it’s HEMASHIELD® products are among the most popular abdominal aortic aneurysm (AAA) grafts. The HEMASHIELD® Gold device has high patency rates and improved biocompatibility, while the HEMASHIELD® Platinum is a woven branch graft that has superior healing rates and years of proven effectiveness. The company also offers an extensive range of heparin-coated, anti-microbial and collagen-coated stent grafts.
Global Surgical Graft Market Segmentation Summary
- Lower Limb Surgical Graft Market
- Aorta Repair Surgical Graft Market – Further Segmented Into:
- Anatomy: Abdominal Aortic Aneurysm Surgical Grafts and Thoracic Aortic Aneurysm Surgical Grafts.
- Extra-Anatomical Bypass Surgical Graft Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
